Cavitaion vs W-BEMS on Central Obesity (NCT07307898) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
Cavitaion vs W-BEMS on Central Obesity
Egypt60 participantsStarted 2024-09-05
Plain-language summary
The purpose of this study is to compare the effects of ultrasound cavitation and whole-body electromyostimulation (WB-EMS) on inflammatory markers in individuals with central obesity.
Who can participate
Age range18 Years – 50 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Adults aged 18-50 years.
* Individuals diagnosed with central obesity, defined as a waist circumference greater than 102 cm in men and 88 cm in women.
* Participants with a stable body weight for at least three months prior to the study.
* No engagement in regular physical activity or weight loss programs in the past six months.
* Willingness to adhere to study protocols and attend all scheduled sessions.
Exclusion Criteria:
* Individuals with chronic diseases other than obesity-related conditions, such as cardiovascular disease, diabetes, or severe hypertension.
* Pregnant or lactating women.
* Individuals with implanted electronic devices (e.g., pacemakers).
* Participants with dermatological conditions or skin infections in the treatment area.
* Individuals undergoing medication that may affect fat metabolism or inflammatory markers.